By Zachery Onyango | Project Leader
Dear Donor,
Thank you for helping Development Alert promote community health and resilience at a time when the Ebola outbreak continues to place enormous pressure on families and health systems.
A significant development was announced on 23 October 2026, when the TUMAINI Phase 2/3 clinical trial of vaccine candidates against Bundibugyo virus disease was launched in Bunia, in the DRC’s Ituri Province. The trial aims to generate evidence needed to improve protection against this strain of Ebola.
This is an important research milestone because there is currently no approved vaccine specifically for Bundibugyo virus disease. The trial is intended to help researchers assess vaccine candidates; it does not mean that an approved vaccine is already available for this outbreak. In the meantime, early detection, appropriate supportive care, infection prevention, and community engagement remain essential.
Research advances must be accompanied by public trust. Communities need clear explanations about what a clinical trial involves, how participants are protected, and where to obtain reliable health information. Communication should be transparent and should never create false expectations about protection or treatment.
Development Alert recognizes the importance of connecting accurate public health information with community needs. By promoting awareness and encouraging people to follow guidance from qualified health professionals, community-focused efforts can complement the work of researchers and response teams.
Your support helps strengthen the community engagement and prevention efforts that remain vital while scientific research continues. Thank you for standing with Development Alert as we work toward safer, better-informed communities.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser